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1. Introduction
  Spiders (Arthropoda: Arachnida) are an ancient and 
successful group of invertebrate animals, widely distributed 
throughout the world. More than 50 000 spider species 
all over the world have been described. Among them, 
about 200 species are actually considered dangerous to 
humans[1-5]. Spider venom is mainly two types, neurotoxic 
and necrotoxic, which affect a variety of vital physiological 
functions in insects and mammals[1,6]. Neurotoxins 
cause paralysis of the nervous system in arthropods and 
vertebrates. Necrotoxins form ulcers and heavy destruction 
in the tissues[1,5,7]. In addition, the venom damages the 
muscular system and blood cells and causes breathing 
difficulties and death. The venom of some species is fifteen 
times more effective than the venom of a viper[5].
  In Turkey, some species of Latrodectus, Steatoda, 
Loxosceles, Cheiracanthium, Segestria, Agelena, Tegenaria, 
Araneus, and Argiope are venomous spider species of known 
medical importance[5,7]. Venomous species of Latrodectus, 
Loxosceles, Phoneutria, Atrax, and Hadronyche share human 
beings’ habitats[1,5,7].
  The genera Loxosceles and Latrodectus include the primary 
species whose venoms produce significant toxic effects in 
humans[2,8,10]. Loxoscelism is caused by spiders that belong 
to the Loxosceles genus and the approximately 100 species 
are found from temperate southern Africa northward 
through the tropics into the Mediterranean region and 
southern Europe, and from temperate and tropical zones of 
North and South America and China[11].
  In loxoscelism, a local necrotic lesion appears, and in 
many cases, loxoscelism or necrotic araneism is considered 
a serious public health problem[8,10-15]. Therefore, national 
poison information services or centers have an important 
role in case of envenomation.
  The aim of this study was to classify and characterize 
spider bites among inquiries to the National Poison 
Information Center (NPIC) between 1995 and 2004, in terms 
of the epidemiology and clinical symptomatology.
 
2. Materials and methods
2.1. Data collection
  NPIC was established in 1986 and is accessible on a 24-
h/7-days-a-week basis. For this study, only cases involving 
spider envenomations in the NPIC database between 1995 
and 2004 were investigated.
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2.2. Epidemiological and clinical data
  Clinical and epidemiological data were obtained from 
the NPIC’s patient records. The following information was 
recorded for each spider bite: demographics (age, gender, 
and geographical location), circumstances of the bite (time, 
date, activity at the time, season), and local and systemic 
effects. Clinical assessment was conducted from records 
during the period 1995-2004. The local group included 
patients with symptoms limited to localized pain, hyperemia, 
burning, and itching. The systemic group included patients 
who displayed local symptoms in addition to one of the 
following systemic symptoms.
3.  Results
  We compiled all reported cases in Turkey of human spider 
bites between 1995 and 2004. Among the gross total of 129 
548 reported poisoning cases of various origins, 1929 (1.5%) 
of all incidents involved animal bites and stings, of which 82 
(4%) were spider bites.
  The incidents were reported in all regions of Turkey. The 
majority of the incidents occurred in the Central Anatolia 
region, followed by the Marmara region, the Mediterranean 
region, and the Black Sea. The Marmara region, despite 
being a relatively small region (8.5% of the total land area of 
Turkey), had the highest population per unit area (Table 1).
  The majority of the incidents happened during the summer 
period (68.28%). The monthly distribution of incidents is 
graphically demonstrated in Figure 1, which displays a clear 
peak in early summer with 30.48% of the incidents occurring 
in July.
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Figure 1. Seasonal distribution of spider bites in Turkey. 
  The gender distribution was 37.20% female and 59.76% 
male as shown Table 2. With respect to age, the 20-29 age 
group presented more spider bites (24.40%) than the other 
groups; the distribution was 17.07% for the 30-39 age group 
and 14.63% for the 0-4 age group.
  The majority of the victims (85.36%) arrived at a local 
healthcare facility or hospital less than 1 h after the incident 
(Table 2). Most of the spider bites occurred in daylight 
(57.89%), as shown in Table 2.
  The spider bites caused local and systemic effects. Local 
symptoms were observed in 60.87% of the cases, including 
local pain (29.16%), edema (29.16%), redness (12.15%), 
itching, debris, burning, and numbness (4.16%). In cases 
where systemic symptoms (39.13%) were observed, the 
most frequent findings in descending order were nausea, 
vomiting, abdominal pain, lethargy, anxiety, weakness, 
somnolence, dyspnea, hypertension, hypotension, and 
hyperthermia (Table 3).
4. Discussion
  There are a few studies of definite bites with expert spider 
identification, but these have been either small studies or 
case reports on spider bites in Turkey. However, as far as 
we know, the present study is the first epidemiological and 
clinical study of spider bites in Turkey. In this study, a 
retrospective analysis of NPIC records showed a total number 
of 82 inquiries on spider bite cases within a period of ten 
years (1995-2004).
  The highest incidence of spider bites took place during the 
warmest months of the year in different regions[12,14,16,17]. 
The present study shows that cases are frequent during hot 
months with the maximum frequency in August. This result 
is in agreement with previous studies. Epidemiological 
studies showed that most cases were seen in women[12,16,17]. 
In our study, the results are a little bit different: spider 
bites were seen mostly in men (59.76%). On the other 
hand, another study reported that the highest incidence of 
accidents was seen in male victims[18]. The majority of bites 
occurred between 08:00 and 20:00[7]. In this study, we also 
found similar results. Cristiano et al stated that most spider 
bites were seen in patients between 20 and 49 years old 
(49.8%)[17]. In this study, similar results were found for the 
same age group (53.66%). In Brazil, the majority of victims 
arrived at the hospital after 3 h[17]. In the present study, 
85.36% of patients presented to healthcare facilities in less 
than 1 h (47.76%) after the bite.
  Biting arthropods are capable of injecting venom or 
allergens that may lead to significant medical reactions. 
Spiders are predators and deliver venom to their prey 
through their chelicerae, or fangs. Most spiders do not 
Table 1
Geographic distribution of spider bites according to regions.
Regions
Patient data Demographic data
Cases (n) Percentage (%) Land area (%) People (/km2)
Central Anatolia 25   30.49   20.0   71
Marmara 20   24.39     8.5 258
Mediterranean 17   20.73   15.0   71
Black Sea 15   18.29   18.0   59
Aegean   3     3.66   10.0   96
Eastern Anatolia   1     1.22   21.0   37
Southeastern Anatolia   1     1.22     7.5 112
Total 82 100.00 100.0   83
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cause clinically important bites or envenomation in humans 
because the spider either possesses toxin that is too weak to 
harm humans or does not possess chelicerae that are large 
and strong enough to penetrate human skin[7,19,20]. Symptoms 
usually resolve between 12 and 72 h after envenomation, 
although paresthesias, muscle aches, weakness, malaise, 
and fatigue may persist for days or weeks[19]. Systemic 
findings depend on the size of the spider, the motivation of 
the spider and the time of the year, the size of the victim, 
the location of the bite, underlying health problems, and the 
age of the victim[20]. Bites of the Loxosceles reclusa result in 
reactions that vary from mild and local to severe ulcerative 
necrosis with eschar formation, known as necrotic[8,9,19]. 
Black widow venom causes depletion of acetylcholine at 
motor nerve endings and the release of catecholamine at 
adrenergic nerve endings[9,19]. Consequently, the majority 
of local effects were pain, swelling, edema, redness, and 
itching, and clinical symptoms occurred in patients such 
as nausea, vomiting, diaphoresis, salivation, hypertension, 
tachycardia, and, rarely, priapism, sweating, hypertension, 
myocarditis, abdominal pain, anxiety, irritability, agitation, 
and headache[9,10,12-16,19-27].
  In our study, local symptoms were observed in 60.87% of 
the cases, including local pain (29.16%), edema (29.16%), 
redness (12.15%), itching, debris, burning, and numbness 
(4.16%), in agreement with previous studies. There were no 
necrotic lesions or ulcers as a consequence of any spider 
bites, but the systemic symptoms of nine spider bites are 
considered in more detail.
  Systemic effects such as nausea, vomiting, abdominal 
pain, weakness, hypotension, hypertension, anxiety, 
lethargy, somnolence, dyspnea, and fever were observed. 
We evaluated these signs according to Clark’s grading scale 
for Latrodectus envenomation[28]. These signs were in grade 
III. In Turkey, spider fauna hasn’t exactly completed yet[29]. 
Nevertheless, black widows (Theridiidae), Latrodectus 
tredecimguttatus called the “Mediterranean black widow” 
have been recorded in Istanbul, Ankara, Adana, Mardin, 
Erciş, and Kars[4].  Steatoda grossa and S. paykulliana are 
dangerous. They can be seen in many places in Turkey. 
Violin Spider (Loxoscelidae) and Loxosceles rufescens 
have been reported in Nusaybin (Mardin), Elbistan 
(Kahramanmaras), Dortyol (Hatay), Kemer (Antalya), Datca 
(Mugla), Didim (Aydın), and Kabatas (Istanbul). Six-eyed 
Table 2
Distribution of spider bites according to patients’ epidemiological characteristics.
Epidemiological characteristics Number of patients (n=82) Percentage (%)
Age ≤4 12 14.63
5-9   8   9.76
10-19 10 12.19
20-29 20  24.40
30-39 14 17.07
40-49 10 12.19
50-59   5   6.10
60-69   2   2.44
≥70   1   1.22
Gender Male 49 59.76
Female 31 37.20
Unknown   2   2.44
Time of day (n=57) Day time   (08:00-20:00) 33 57.89
Night time (20:00-08:00) 24 42.11
Hospital arrival time (n=67) ≤1 32 47.76
1-2   8 11.94
2-3   1   1.49
≥4 26 38.81
Admission center Local hospital 70 85.36
Private medical center 10 12.20
Primary health center   2   2.44
Table 3
Details of the clinical effects occurring in nine patients after spider bites.
Case No./Year Age/Sex Month Province Location Admission time Systemic effects
11933/2001 40/F October Konya Central Anatolia <1 h Hyperthermia
12473/2003 33/M August Sivas Central Anatolia 16 h Nausea, vomiting, abdominal pain
11128/2002 21/M Semptember Osmaniye Mediterranean 12 h Anxiety
  5329/2004 12/M July Antalya Mediterranean   9 h Pain and hypertension
  2046/2004  6/F May Izmir Aegean   5 h Numbness, weakness, hyperthermia
  8488/2001 27/M August Kocaeli Marmara U Hypotension
  6520/2001   2/M July Cankırı Central Anatolia U Lethargy
12594/2003 60/F October Kastamonu Black Sea   5 h Somnolence
12477/2003 16/M August Yozgat Central Anatolia   1 h Dyspnea
U: Unknow, M: Male, F: Female.
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spiders, Segestria florentina, and S. senoculata, have been 
reported in Muğla, İzmir, and İstanbul[4,8,30,31](Figure 2). 
Therefore, Latrodectus spider species may be responsible for 
accidents.
Figure 2. Map of Turkey and locations of previously designed studies 
or case reports.
  In summary, the majority of spider bites occurred in adults, 
and individuals of both genders were at approximately equal 
risk of spider bites. The majority of spider bites were seen 
during the daytime. The accidents were seasonal and occur 
most frequently during the warmest time of the year. The 
majority of patients were admitted to healthcare facilities 
in less than 1 h. After the spider bite, local and systemic 
symptoms were observed, but no necrotic lesions were 
observed.
  In conclusion, there are venomous spiders of medical 
importance known in the Turkey. Therefore, each victim 
should be asked about bite history. Even if the spider is not 
captured, medical professionals must be able to identify 
spider bites and should consider the etiology of spiders, 
according to the clinical and epidemiological findings and 
all symptoms. All patients and especially pediatric patients 
should be admitted to the hospital. Identifying spiders may 
be considered a useful clinical and epidemiological tool in 
determining the incidence and risk of spider bites.
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